These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2020943)

  • 21. Electrolyte disturbances caused by intravenous contrast media.
    Hayakawa K; Maeda M; Mitsumori M; Torizuka T; Okuno Y; Tanaka F; Matsui A; Misaki T
    Radiat Med; 1992; 10(5):171-5. PubMed ID: 1438924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxicity of high- and low-osmolality contrast media.
    Jevnikar AM; Finnie KJ; Dennis B; Plummer DT; Avila A; Linton AL
    Nephron; 1988; 48(4):300-5. PubMed ID: 3362276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo effects of contrast media on coronary thrombolysis.
    Pislaru S; Pislaru C; Szilard M; Arnout J; Van de Werf F
    J Am Coll Cardiol; 1998 Oct; 32(4):1102-8. PubMed ID: 9768739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic effectiveness and safety of currently available X-ray contrast media].
    Sergeev PV; Sviridov NK; Poliaev IuA; Shimanovskiĭ NL
    Vestn Rentgenol Radiol; 1999; (6):45-9. PubMed ID: 10714233
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
    Qureshi NR; den Heijer P; Crijns HJ
    Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Increased thrombin synthesis in patients with fulminant hepatic failure and its treatment with antithrombin III evaluated by plasma levels of thrombin-antithrombin III complex].
    Tomiya T; Ogata I; Hayashi S; Fujiwara K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2473. PubMed ID: 3065544
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of fibrillation with isotonic contrast media for intra-arterial coronary digital subtraction angiography.
    Morris TW; Hayakawa K; Sahler LG; Ekholm S
    Diagn Imaging Clin Med; 1986; 55(3):109-13. PubMed ID: 3522039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.
    Hill JA; Winniford M; Cohen MB; Van Fossen DB; Murphy MJ; Halpern EF; Ludbrook PA; Wexler L; Rudnick MR; Goldfarb S
    Am J Cardiol; 1993 Oct; 72(11):770-5. PubMed ID: 8213508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ionized calcium levels in coronary sinus blood during coronary angiography: effects of four contrast media.
    Mitsumori M; Hayakawa K; Torizuka T; Okuno Y; Monji T; Uwatoko H; Kitamura K; Abe M
    Radiology; 1992 Apr; 183(1):159-61. PubMed ID: 1549664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic degeneration of human microvascular endothelial cells induced by iodinated contrast media.
    Furuta W; Sendo T; Kataoka Y; Oishi R
    Acad Radiol; 2001 Feb; 8(2):158-61. PubMed ID: 11227644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Miscellaneous adverse effects of low-versus high-osmolality contrast media: a study revised.
    Brismar J; Jacobsson BF; Jorulf H
    Radiology; 1991 Apr; 179(1):19-22. PubMed ID: 1826061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents.
    Sendeski M; Patzak A; Persson PB
    Invest Radiol; 2010 Aug; 45(8):453-7. PubMed ID: 20458252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephrotoxicity of iohexol, iopamidol and ioxaglate.
    Tverdal A; Haider T
    Can Assoc Radiol J; 1991 Jun; 42(3):226-7. PubMed ID: 2054686
    [No Abstract]   [Full Text] [Related]  

  • 34. New contrast media.
    Med Lett Drugs Ther; 1987 Apr; 29(738):43-4. PubMed ID: 3574237
    [No Abstract]   [Full Text] [Related]  

  • 35. Dealing with the highs and lows of contrast agents in left main disease.
    Hardee MS; Bashore TM
    Cathet Cardiovasc Diagn; 1997 Dec; 42(4):380. PubMed ID: 9408614
    [No Abstract]   [Full Text] [Related]  

  • 36. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
    Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
    Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionic contrast media induced more apoptosis in diabetic kidney than nonionic contrast media.
    Lee HC; Chang JG; Yen HW; Liu IH; Lai WT; Sheu SH
    J Nephrol; 2011; 24(3):376-80. PubMed ID: 20890877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new contrast agents: a perspective.
    Bettmann MA
    Cardiovasc Intervent Radiol; 1986; 9(4):173-5. PubMed ID: 3094946
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse reactions during intravenous urography: are these due to histamine release?
    Herd CM; Robertson AR; Frewin DB; Taylor WB
    Br J Radiol; 1988 Jan; 61(721):5-11. PubMed ID: 2450612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative tolerability of contrast media used for coronary interventions.
    Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
    Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.